Urethral Dilators Market Growth & Trends
The global urethral dilators market size is anticipated to reach USD 360.80 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.7% from 2022 to 2030. Rising cases of urinary stones and urinary tract infections and growing demand for cost-effective procedures for dilation are expected to propel the growth of the market. Rise in the population suffering from urethral stricture and meatal stenosis is expected to enhance the industry growth. Urethral stricture is a common problem and is usually caused by scar tissue forming near the urethra, often after surgery or illness. These factors have led to an increase in the sale of urethral dilators in the market.
The market has been adversely impacted by the COVID-19 pandemic as the majority of elective urological procedures were postponed to free-up limited space in healthcare settings to treat COVID-19 patients. For instance, a recently published survey from the European Association of Urology Section of Uro-technology found that the bed occupancy in the urological departments was reduced by 48.6% in order to hospitalize COVID-19 patients, and clinical activities were halted in 54.2% of the hospitals. However, COVID-19 patients have subsequently shown new or worsening symptoms of overactive bladder (OAB), which might be expected to create a favorable environment for industry growth in the near future.
Request a free sample copy or view report summary: Urethral Dilators Market Report
Urethral Dilators Market Report Highlights
On the basis of usage, the disposable segment accounted for the leading revenue share of over 60.0% in 2021 owing to the ease of use, low risk of transmission of diseases from one patient to another, and low cost
Based on application, the urethral stricture segment captured a dominant revenue share of over 50.0% in 2021 owing to the increasing prevalence of urethral strictures, especially among the male population
On the basis of end-user, the hospitals segment held the largest revenue share of over 40.0% in 2021 due to an increase in the number of patients suffering from prostate cancer, kidney stones, and others that obstruct the urethral passage, hence requiring urethral dilation or incision under local anesthesia. This is expected to increase the hospitalization rates
North America led the market with a revenue share of over 30.0% in 2021. The presence of prominent players, advanced healthcare infrastructure, and high public funding in the healthcare system are some of the factors responsible for the regional growth
Comments